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Introduction: Infections caused by multiresistant Pseudomonas aeruginosa (MR-PA) have been 
associated with persistent infections and high mortality in acquired immunodeficiency 
syndrome (AIDS) patients. therefore, understanding the predisposing factors for infection/
colonization by this agent is critical for controlling outbreaks caused by MR-PA in settings 
with AIDS patients. 
Objective and methods: to analyze the presence of factors associated with the acquisition 
of an epidemic MR-PA strain in a hospital with AIDS-predominant admission. A case-
control study was carried out in which cases and controls were gathered from a 
prospective cohort of all hospitalized patients in an infectious disease hospital during 
a five-year study period. 
Results: Multivariate logistic regression analysis demonstrated that enteral nutrition 
(OR = 14.9), parenteral nutrition (OR = 10.7), and use of ciprofloxacin (OR = 8.9) were 
associated with a significant and independent risk for MR-PA acquisition.
Conclusions: Although cross-colonization was likely responsible for the outbreaks, the 
use of ciprofloxacin was also an important factor associated with the acquisition of an 
epidemic MR-PA strain. More studies are necessary to determine whether different types 
of nutrition could lead to modification of gastrointestinal flora, thereby increasing the 
risk for infection/colonization by MR-PA in this population.
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Introduction
Infections caused by multiresistant Pseudomonas aeruginosa (MR-PA) 
are usually associated with high mortality rates,1 especially in 
patients with acquired immunodeficiency syndrome (AIDS).2 
In addition, persistent MR-PA infections have been observed in 
these patients.2 therefore, understanding the predisposing 
factors for infection/colonization by MR-PA is critical to 
decrease the incidence and mortality rates of MR-PA infections 
in this special population. 
Several previous studies have assessed the risk 
factors for the acquisition or emergence of MR-PA, 
including antimicrobial use, previous hospitalization, 
severity of illness, surgery, and immunosuppression.1,3-20 
Among immunocompromised patients with human 
immunodeficiency virus (HIV) infection or AIDS, few studies 
have shown prior hospitalization, antimicrobial use, and 
CD4 cell count below 50/mm3 as risk factors for P. aeruginosa 
infection.21-23 none of these HIV/AIDS studies assessed the 
risk factors for acquisition of MR-PA strains. 
During an outbreak of nosocomial infections, an unique 
genotype is expected to be present, and a common source 
or horizontal transmission is likely to occur. Although 
antimicrobial pressure may play a lesser role, it is still 
present and is a contributing factor to epidemics.24 Case-
control studies performed solely in patients colonized with 
a single clone could potentially measure the contribution 
of antibiotics to the outbreak of infections caused by the 
resistant organism.
Understanding the risk factors for acquisition of MR-PA 
infection/colonization could help to control and prevent 
its occurrence. It could also contribute to early diagnosis 
and treatment of MR-PA infection, thereby reducing MR-PA 
mortality rates. this knowledge would be especially 
important in settings in which most admitted patients are 
immunocompromised and the pathogen causes outbreaks, 
persistence, and high mortality rates due to infections.2
Material and methods
Study design, institution and population
this case-control study was designed from a prospective 
surveillance program utilized for controlling nosocomial 
infection in an infectious disease hospital with 26 beds, 
including two to four intensive care beds, located in Rio 
de Janeiro, Brazil. the surveillance, description of MR-PA 
outbreaks, intervention control program, antibiotic 
susceptibility profile, and molecular characteristics of MR-PA 
isolates, as well as the clinical characteristics of patients 
with MR-PA infection/colonization were described in detail 
elsewhere.2 During the five-year study period (April 2002 to 
February 2007), two outbreaks caused by MR-PA were detected.2 
Pulsed field gel electrophoresis (PFGE) typing performed on 
all randomly preserved MR-PA strains isolated during the 
study period, including strains from the outbreaks, the inter-
epidemic period, and environmental samples collected close 
to MR-PA–positive patients, showed that all strains had the 
same genetic profile.2
Both cases and controls selected for this risk factor study 
were included only once. the study was approved by the 
institutional ethics committee. 
Inclusion and exclusion criteria 
Patients were eligible for inclusion as cases upon their 
first detection of MR-PA from clinical or surveillance 
cultures. Patients were included as cases only if their 
first positive MR-PA sample was collected after 48 
hours of admission to the study hospital. Potential case 
patients were excluded if they had MR-PA isolated prior 
to the study period, before or during the first 48 hours of 
hospital admission. Control patients, three to each case, 
were randomly selected from the group of concurrently 
hospitalized patients who remained hospitalized through 
the date that MR-PA was isolated from the original case 
patient. Potential control patients were excluded if they 
had MR-PA isolation in any biological material prior to or 
during the study hospitalization. Control patients were also 
excluded if they were treated empirically with polymyxin B, 
which could prevent the detection of MR-PA strains in clinical 
and surveillance cultures. All case and control patients were 
adults. there was no matching between cases and controls 
with the purpose of examining all potential variables as factors 
associated with MR-PA acquisition in the study hospital.
Collection of variables
For each selected patient complete medical record, laboratory 
results, and infection control database were reviewed to 
confirm the prospectively collected data. Factors associated 
with infection/colonization with MR-PA included gender, age, 
referred from another hospital, underlying disease, time at 
risk (which was defined either as the length of stay prior to 
the date that MR-PA was first detected in case patients, or 
as the entire length of stay for the control patients), and the 
following variables during time at risk: intensive care unit 
(ICU) hospitalization, presence of central vascular catheter, 
mechanical ventilation, use of bladder catheter, thoracic 
drain, any kind of drainage, hemodialysis, bronchoscopy, total 
parenteral nutrition, enteral nutrition, and antibiotic therapy 
utilized for more than two days. 
Statistical analysis 
For data processing, Epi Info 6.0 (CDC, Atlanta – USA), 
Statistical Package for Social Sciences 15.0 (SPSS Inc., Chicago, 
Illinois – USA), and R 2.4.1. (package logistf) softwares were 
used. Exploratory analysis was performed for all variables to 
describe the distribution, central tendency, and variability. 
Univariate analysis was used to compare case and control 
groups through the chi-square (χ2) or Fisher’s exact test 
when required for dichotomous variables. the difference 
between means for continuous independent variables was 
tested using the paired Student’s t-test. A p-value of < 0.05 
was considered significant in all statistical tests.
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Multiple logistic regression analysis was used to determine 
statistically significant factors independently associated with 
MR-PA acquisition. those variables with p-values < 0.20 in 
univariate analyses were included in the multivariate analysis. 
Firth’s correction was used for correcting the estimates and 
confidence intervals (CIs) by penalized likelihood in univariate 
and multivariate analyses.25 Variables were checked for 
confounding, collinearity, and interaction. the goal was to 
derive a model with the smallest set of independent variables 
to predict acquisition of MR-PA. A significance level (p-value) 
of 0.05 was required for maintaining the variables in the model. 
Results 
Study population
Among 44 patients who were identified as having P. aeruginosa 
isolates in clinical or surveillance samples during the study 
period, 29 were excluded from the case-control study for 
the following reasons: 26 patients had isolates with a non-
MR-PA susceptibility pattern, two patients had isolates with 
these resistant patterns prior to or during the first 48 hours 
of admission, and one patient had no records available for 
review. Except for this last patient, all the patients from MR-PA 
outbreaks (n = 11) were selected as case patients. Among the 15 
case patients 13 had MR-PA infection, and two had colonization 
with MR-PA strains. 
A total of 45 control patients were selected according to the 
inclusion and exclusion criteria. 
Patient characteristics and risk factors
Case patients were similar to control patients with respect to 
gender, age, and referral from other hospitals (table 1). Most 
of the cases and controls were immunocompromised (14/15 
cases [93%]; 31/45 controls [69%]) due to AIDS (nine cases 
and 28 controls) or human t-lymphotropic virus (HtLV-1) 
infection (four cases and two controls); one control was 
co-infected with HIV and HtLV-1. All cases and controls with 
HtLV-1 had urinary tract infections (UtIs) caused by other 
bacterial species identified previous to the acquisition of 
MR-PA for the cases, and upon admission (two patients) or 
during hospitalization (one patient) for controls. time at risk 
was not different (p = 0.38) between the cases (mean 33.5 
days; SD 43.3; median 24 days) and controls (mean 24.3 days; 
SD 18.6; median 19 days). 
Case patients were more likely to have experienced the 
following, prior to being infected or colonized by the MR-PA 
strain, than control patients, during their entire hospitalization 
period (table 1): bladder (OR = 29.0) or central vascular 
(OR = 16.20) catheter insertion; admission into ICU (OR = 12.07); 
hemodialysis (OR = 11.86); enteral (OR = 10.61) or parenteral 
(OR = 8.11) nutrition; mechanical ventilation (OR = 9.82); or use 
of amikacin (OR = 35.61), vancomycin (OR = 10.45), cefepime 
(OR = 6.85), or ciprofloxacin (OR = 4.83). 
However, on multivariate analysis (table 2), after adjusting 
for all significant variables, only the following variables 
remained significantly and independently associated 
with MR-PA acquisition: enteral nutrition (OR = 14.93; 95% 
CI 3.29-94.13), parenteral nutrition (OR = 10.74; 95% CI 1.51-
91.88), and the use of ciprofloxacin (OR = 8.87; 95% CI 1.56-66.38). 
Outcomes
Death during hospitalization occurred in 11 of 15 case patients 
(73%), compared with four control patients (9%) (p < 0.001). 
Except for one case patient who was lost during follow up, 
the only two case patients who outlived hospitalization 
died roughly four months thereafter with recurrent MR-PA 
infections. thus, the mortality rate was 92% (11/12) among 
case patients during the five years of study. the median length 
of hospital stay was significantly greater for case patients 
(33 days) than for control patients (18 days) (p = 0.007).
Discussion 
the present analysis stemmed from a case-control study from 
a prospective cohort gave a stronger epidemiological point 
of view. Strain typing methods were used in all randomly 
preserved epidemic and inter-epidemic strains, confirming 
the clonality of MR-PA strains.2 thus, the effect of the clonal 
dissemination on the acquisition of MR-PA isolates could be 
assessed. therefore, in this discussion section, other factors 
related to the epidemiology of the outbreaks that were also 
identified in univariate analysis but not maintained in the final 
model will be considered. 
Several studies published to date that have used molecular 
analysis to assess risk factors have shown similarities between 
MR-PA strains, and have linked some of the identified risk 
factors with cross-transmission.1,3,6,13,14,17,19,20 Hemodialysis 
was one of the factors that was associated with the outcome 
in univariate analysis in the present study but was not kept 
in the final model. temporal, spatial and clinical associations 
between this variable and the dependent variable (infection 
or colonization by MR-PA strain during hospitalization) were 
observed during the study.2 From an observational standpoint, 
it is possible that undergoing hemodialysis was related to 
MR-PA cross-infection among the studied population.2 Four 
sequential patients from the first outbreak acquired MR-PA 
infection after undergoing hemodialysis performed by the 
same technician. After assigning a different technician to 
each patient, control of the first outbreak was obtained.2 
From this point on, hemodialysis was no longer related to 
MR-PA acquisition in any other patient.2 Some authors have 
implicated hemodialysis4,6,11,26 or renal failure8,9,12 as factors 
associated with MR-PA acquisition4,6,8,11,12 or infection9,26 
in multivariate4,8,9,11,12,26 or univariate analysis.6 Although 
unpredictable drug metabolism associated with altered 
creatinine clearance in patients with renal insufficiency may 
explain the association between hemodialysis and MR-PA 
acquisition,8,12 the molecular analyses of the tested strains 
corroborate the observation that it was probably related to the 
horizontal transmission of MR-PA during the first outbreak.2 
When resistance results from a cloning mechanism, the 
potential risk factors should be evaluated considering failure of 
measures to prevent cross-transmission of the microorganism. 
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Variable                        No. (%) of patients Unadjusted OR p-value
 Case group (n = 15) Control group (n = 45) (95% CI)  
Characteristic
 Male gender 11 (73) 29 (64) 1.4 (0.4-5.4) 0.568
 Median age, years 50 40 1.0 (1.0-1.1) 0.121
 Referred from another hospital 2 (13) 2 (4) 3.2 (0.5-22.9) 0.225
 Median hospital stay, days 33 18 1.0 (1.0-1.1) 0.007
 Underlying disease (AIDS and HtLV) 14 (93) 31 (69) 4.5 (0.9-43.3) 0.060
 ICU stay 12 (80) 10 (22) 12.1 (3.3-54.9) < 0.001
Procedure
 Central vascular catheter 13 (87) 11 (24) 16.2 (4.1-92.5) < 0.001
 Mechanical ventilation 11 (73) 9 (20) 9.8 (2.8-39.8) < 0.001
 Bladder catheter 14 (93) 11 (24) 29.0 (6.1-285.9) < 0.001
 thoracic drain 2 (13) 1 (2) 5.5 (0.7-64.0) 0.108
 Any kind of drainage 3 (20) 3 (7) 3.4 (0.7-18.1) 0.141
 Hemodialysis 4 (27) 2 (4) 11.9 (1.9-128.1) 0.021
 Bronchoscopy 0 4 (9) 3.4 (0.3-455.3) 0.357
 type of nutrition - - - 0.001
 total parenteral nutrition 3 (20) 3 (7) 8.1(1.4-52.0) -
 Enteral nutrition 8 (53) 6 (13) 10.6 (2.7-47.9) -
Antibiotic therapy
 Ceftazidime 0 3 (7) 2.6 (0.2-350.8) 0.499
 Cefepime 11 (73) 12 (27) 6.9 (2.0-26.8) 0.001
 Ceftriaxone 2 (13) 4 (9) 1.7 (0.3-8.7) 0.537
 Ciprofloxacin 5 (33) 4 (9) 4.8 (1.2-21.2) 0.029
 Levofloxacin 1 (7) 1 (2) 3.1 (0.2-40.1) 0.357
 Imipenem 4 (27) 5 (11) 2.9 (0.7-12.0) 0.147
 Meropenem 1 (7) 3 (7) 1.3 (0.1-8.4) 0.825
 Piperacillin-tazobactam 2 (13) 5 (11) 0.7 (0.2-4.5) 0.711
 Polymyxin B 0 0 - -
 Ofloxacin 1 (7) 4 (9) 1.1 (0.2-11.1) 0.962
 Amikacin 4 (27) 0 35.6 (3.4-4849.2) 0.001
 ticarcillin-clavulanic acid 0 2 (4) 1.8 (0.1-251.1) 0.698
 Vancomycin 8 (53) 4 (9) 10.5 (2.8-45.5) < 0.001
 Sulfamethoxazole-trimethoprim 7 (47) 20 (44) 1.1 (0.3-3.5) 0.873
OR, odds ratio; CI, confidence interval; AIDS, acquired immunodeficiency syndrome; HtLV, human t-lymphotropic virus;  ICU, intensive care unit.
Table 1 – Association of studied variables with multiresistant Pseudomonas aeruginosa infection/colonization 
Factor Crude OR Adjusted OR  95% CI p-value
Ciprofloxacin
 Yes 4.8 8.9 1.6-66.4 0.013
 no 1.0 1.0 - -
type of nutrition
 Parenteral feeding 8.1 10.7 1.5-91.9 0.018
 Enteral feeding 10.6 14.9 3.3-94.1 0.003
 Without nutrition 1.0 1.0 - -
OR, odds ratio; CI, confidence interval.
Table 2 – Factors significantly associated with multiresistant Pseudomonas aeruginosa infection/colonization on 
multivariate logistic regression analysis
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Case patients were admitted to the ICU and underwent 
several invasive procedures more frequently than control 
patients. none of these variables were remained significant 
in the multivariate analysis. However, all these factors 
were previously described as risks for MR-PA acquisition 
in multivariate analysis, and all could be related to MR-PA 
cross-transmission. It should not be surprising that urinary 
catheterization was among these factors in the univariate 
analysis of the present study. A number of studies have 
shown urinary catheterization as an independent risk factor 
for MR-PA infection/colonization.5,7,10,16,18 However, none 
of these studies used genotypic methods to show similarity 
between strains, but Eagye et al. considered cross-infection 
related to this association.18 Studies have suggested that HtLV-
1-infected patients are at increased risk for UtI.27 Patients with 
HtLV-1 infection and myelopathy/tropical spastic paraparesis 
were well represented among cases (five of 15 cases). All had 
prolonged urinary catheterization due to neurogenic bladder, 
and had non-MR-PA UtIs before MR-PA acquisition. In all 
these patients, the urinary catheter was the likely source for 
their MR-PA acquisition (four UtIs, one urinary sepsis, and 
one urinary-tract colonization by MR-PA).2 All of them had 
previously used antibiotics to treat their non-MR-PA UtIs or for 
other reasons. those antibiotics could be responsible for MR-PA 
selection, though cross infection might be another explanation 
for their MR-PA acquisition. Although molecular typing was not 
performed on all isolates, it was performed for those isolates 
that were randomly preserved. two of the PFGE tested strains 
were isolated from the two HtLV-1 patients, one during the 
inter-epidemic period, and the other in the second outbreak. 
In addition, most of the positive cases using bladder catheters 
were temporally and spatially related with another positive 
case in the ICU or wards.2 All of these elements indicate the 
need to focus on the prevention of catheter-associated UtIs, 
especially in HtLV-1 patients. 
nasogastric feeding and enteral nutrition were previously 
observed as factors associated with MR-PA infection or 
acquisition after adjusting for the severity index,5,15 although 
these studies did not include patients with HIV or AIDS. 
Artificial feeding appears to be responsible for a weakening 
of the mucous membranes in the digestive system, relative 
immunodeficiency, modification of the commensal gut flora, 
and an increased risk of bacterial translocation from the 
gastrointestinal tract into the general circulation.5,28 Both total 
enteral nutrition (tEn) and total parenteral nutrition (tPn) 
induce modifications in the intestinal microflora.28 During tPn, 
a homogeneous decrease occurs in both aerobic and anaerobic 
bacteria, whereas during tEn anaerobic bacteria are decreased, 
and aerobic bacteria are increased. this imbalance may play 
a role in the pathophysiology of tEn-induced diarrhea.28 
Additionally, enteral glutamine supplementation prevents 
bacteraemia by P. aeruginosa in adult burn patients.29 A 
significant link between enteral and parenteral nutrition 
and MR-PA infection/colonization was found. However, 
since only MR-PA-negative patients in close contact with 
an MR-PA-positive case had rectal swabs performed in the 
present study, MR-PA colonization in the gastrointestinal 
tract was not investigated. Because case patients in this 
study were mostly immunocompromised and had AIDS, the 
alterations caused by enteral feeding could be compounded 
by gastrointestinal problems usually experienced by these 
patients. therefore, the finding that the type of nutrition is 
a factor associated with MR-PA acquisition deserves further 
investigation. the role of enteral nutrition in AIDS patients 
and its relation with MR-PA acquisition should be further 
evaluated in order to prevent infection with MR-PA strains. 
nevertheless, the possibility of cross-transmission interfering 
with these findings cannot be ruled out. 
As reported by several authors, prior exposure to 
ciprofloxacin is an important risk for MR-PA infection/
acquisition.4-7,9,12,16 to our best knowledge, this is the 
first study that describes this factor during MR-PA clonal 
dissemination over a long period of time, confirming the role of 
this antibiotic in contributing to MR-PA epidemic. the risk 
of acquiring MR-PA during MR-PA epidemics in this study 
hospital was almost nine times greater in patients who had 
received ciprofloxacin than in those who had not received 
this antibiotic. In addition, some differences were observed in the 
antibiotic susceptibility pattern of the MR-PA isolate strains 
during the two outbreaks. However, all preserved isolates had 
an identical genetic pattern by PFGE.2 these differences suggest 
that MR-PA probably acquired a new resistance mechanism 
or derepressed one during the study.2 Sequential emergence 
of resistance is likely because different antibiotics were 
administered at different times following the development 
of resistance in our patients.2 therefore, cross-transmission 
was an important feature of the outbreaks, whereas prior use 
of ciprofloxacin was also an important factor that may have 
contributed to the differences in antibiotic susceptibilities.
the present study has several limitations. First, while 
surveillance cultures by rectal swabs were performed 
systematically during outbreaks, they were performed 
non-systematically during inter-epidemic periods.2 Also, 
selective media for rectal swabs to detect target antibiotic-
resistant Gram-negative bacteria, including MR-PA, was 
not used.2 therefore, some bias could have occurred in the 
selection of the control group, leading to an underestimation 
of the effect of factors associated with MR-PA acquisition. to 
what extent cross-transmission of MR-PA among patients 
influenced the results, and whether this may have weakened 
the association between MR-PA acquisition and antibiotic use, 
is not possible to ascertain. Additionally, the present study was 
conducted in an infectious disease hospital, with AIDS as the 
predominant admission diagnosis. therefore, these findings 
might not be applicable to other settings. Finally, given the 
fairly small number of patients, the present study may have 
lacked statistical power for detecting the effects of some other 
studied variables. the number of case patients was probably 
restricted by improved infection control.2 In addition to host 
or environmental factors, intrinsic virulence factors might 
contribute to the ability of strains to infect or colonize. 
Conclusion
the findings from this study are important to guide 
prevention measures, early diagnosis, and treatment 
of MR-PA infection in the study population. Infection 
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control measures are extremely important in limiting 
the dissemination of MR-PA and in preventing infections, 
while an antimicrobial stewardship program is required 
to prevent resistance development in the hospital setting. 
these measures would increase the chances of effectively 
treating infected patients and decrease the probability of 
cross-transmission events of MR-PA strains. Other factors 
associated with MR-PA acquisition, such as nutrition type, 
deserve further study in order to continue to improve 
prevention and treatment. 
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